Fibromyalgia Is Not a Rheumatologic Disease Anymore

Article

George Griffing, MD, Professor of Medicine at St. Louis University, discusses new insights and therapies on the horizon for fibryomyalgia.

George Griffing, MD, Professor of Medicine at St. Louis University, discusses new insights and therapies on the horizon for fibryomyalgia.

To access this third party resource, click here.

Related Videos
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
Kaitlin Mayne, MBChB | Credit X.com
Mona Shahriari, MD | Credit Central Connecticut Dermatology
Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care | Image Credit: Johns Hopkins University
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
© 2024 MJH Life Sciences

All rights reserved.